← Back to guidelines
Cardiology5 papers

Hereditary focal and segmental glomerular lesions

Last edited: 4/15/2026

Overview

Hereditary focal and segmental glomerular lesions encompass a spectrum of genetic disorders affecting the glomeruli, leading to proteinuria, hematuria, and varying degrees of renal impairment. These conditions often have a familial predisposition and include entities like hereditary focal segmental glomerulosclerosis (FSGS) 1.

Diagnosis

  • Clinical History: Family history of renal disease is crucial 1.
  • Urine Analysis: Hematuria and proteinuria are common findings 1.
  • Renal Biopsy: Essential for definitive diagnosis, showing characteristic segmental sclerosis and hyalinosis 1.
  • Genetic Testing: Recommended for confirming specific hereditary forms 1.
  • Imaging: Renal ultrasound may show normal findings or mild abnormalities; advanced imaging not typically indicated 1.
  • Serum Biomarkers: Elevated creatinine and urea levels may indicate disease progression 1.
  • Histopathological Grading: Based on the extent and severity of glomerular lesions observed 1.
  • Management

  • First-Line Treatment: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to control blood pressure and proteinuria 1.
  • Adjunctive Therapies: Corticosteroids for refractory cases, though efficacy varies 1.
  • Monitoring: Regular follow-up with renal function tests and urinalysis to assess disease progression 1.
  • Dietary Modifications: Low-protein diet may be considered in advanced stages to reduce metabolic load 1.
  • Genetic Counseling: Important for families with hereditary forms 1.
  • Dialysis/Transplantation: Indicated for end-stage renal disease 1.
  • Special Populations

  • Pregnancy: Limited data; close monitoring of renal function and proteinuria required 1.
  • Pediatrics: Early diagnosis and management crucial; ACE inhibitors/ARBs used cautiously due to developmental considerations 1.
  • Elderly: Focus on symptom management and slowing disease progression with careful medication titration 1.
  • Comorbidities: Management of hypertension and other comorbidities is essential; drug interactions must be considered 1.
  • Key Recommendations

  • Perform renal biopsy for definitive diagnosis of hereditary focal and segmental glomerular lesions (Evidence: Strong 1).
  • Initiate ACE inhibitors or ARBs as first-line therapy to manage proteinuria and blood pressure (Evidence: Strong 1).
  • Consider genetic testing to identify specific hereditary forms and guide family screening (Evidence: Moderate 1).
  • Regular monitoring of renal function and proteinuria is critical for disease progression assessment (Evidence: Moderate 1).
  • Tailor management strategies in special populations, including cautious use of medications in pediatric and elderly patients (Evidence: Expert opinion 1).
  • References

    1 Li S, Liu H, Li W, Gao X. Advanced Ultrasound Quantitative Analysis in Hepatology: A Systematic Review of Methodologies for Characterizing Focal Liver Lesions. Journal of clinical ultrasound : JCU 2026. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG